Katsura Mizushima Selected Research

Bile Acids and Salts (Bile Acids)

7/2021	Identification of colorectal neoplasia by using serum bile acid profile.
7/2020	Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids.
7/2019	Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice.
3/2016	Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsura Mizushima Research Topics

Disease

34	Colitis 01/2024 - 12/2008
27	Inflammation (Inflammations) 01/2024 - 09/2007
11	Ulcerative Colitis 01/2024 - 12/2008
11	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2020 - 01/2011
10	Neoplasms (Cancer) 05/2022 - 05/2010
7	Ulcer 01/2021 - 07/2010
6	Wounds and Injuries (Trauma) 01/2022 - 07/2010
5	Ischemia 03/2022 - 10/2005
5	Dysbiosis 11/2020 - 03/2016
5	Carcinogenesis 03/2018 - 12/2007
4	Type 2 Diabetes Mellitus (MODY) 11/2022 - 04/2008
4	Insulin Resistance 01/2019 - 05/2007
3	Obesity 03/2022 - 03/2008
3	Body Weight (Weight, Body) 01/2022 - 01/2019
3	Non-alcoholic Fatty Liver Disease 05/2021 - 07/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 07/2014
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2024 - 10/2023
2	Reperfusion Injury 03/2022 - 03/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2021 - 08/2020
2	Intestinal Diseases (Diseases, Intestinal) 05/2021 - 12/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2014
2	Fatty Liver 07/2019 - 09/2011
2	Metabolic Diseases (Metabolic Disease) 01/2019 - 03/2013
2	Colorectal Neoplasms (Colorectal Cancer) 11/2018 - 08/2010
2	Stomach Ulcer (Gastric Ulcer) 01/2018 - 07/2010
2	Aberrant Crypt Foci 03/2016 - 06/2013
2	Pneumonia (Pneumonitis) 01/2015 - 09/2007
2	Hyperthermia 07/2014 - 01/2010
2	Fibrosis (Cirrhosis) 09/2011 - 01/2011
2	Hypoxia (Hypoxemia) 01/2006 - 01/2004
1	Abdominal Pain (Pain, Abdominal) 01/2024

Drug/Important Bio-Agent (IBA)

12	Sulfonic AcidsIBA 11/2021 - 07/2010
10	Carbon MonoxideIBA 03/2022 - 04/2009
10	Messenger RNA (mRNA)IBA 01/2022 - 03/2008
9	CytokinesIBA 06/2022 - 11/2006
8	Proteins (Proteins, Gene)FDA Link 05/2022 - 05/2010
8	Peroxidase (Myeloperoxidase)IBA 05/2021 - 03/2011
6	Heme Oxygenase-1IBA 03/2022 - 12/2008
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2007
6	sodium sulfate (sodium bisulfate)FDA LinkGeneric 07/2020 - 05/2010
6	Dextrans (Dextran)FDA Link 07/2020 - 05/2010
5	Dextran SulfateIBA 01/2024 - 06/2011
5	guar gum (guaran)IBA 05/2022 - 10/2016
5	sym-trinitrobenzeneIBA 11/2021 - 08/2013
5	Indomethacin (Indometacin)FDA LinkGeneric 02/2014 - 02/2011
4	Bile Acids and Salts (Bile Acids)IBA 07/2021 - 03/2016
4	Therapeutic UsesIBA 01/2021 - 08/2013
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2014 - 02/2011
3	Volatile Fatty AcidsIBA 10/2023 - 03/2016
3	Peptides (Polypeptides)IBA 10/2022 - 05/2013
3	Dietary Fiber FDA Link 05/2022 - 07/2020
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2006
3	Carotenoids (Carotene)IBA 08/2020 - 04/2008
3	Insulin (Novolin)FDA Link 01/2019 - 05/2007
3	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 01/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011 - 03/2008
2	Interleukin-12 (IL 12)IBA 01/2024 - 03/2021
2	Mesalamine (Mesalazine)FDA LinkGeneric 10/2023 - 11/2022
2	16S Ribosomal RNAIBA 11/2022 - 07/2020
2	Fluorouracil (Carac)FDA LinkGeneric 06/2022 - 03/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2022 - 12/2015
2	SolutionsIBA 01/2022 - 01/2021
2	LycopeneIBA 01/2022 - 08/2020
2	MucinsIBA 11/2021 - 12/2017
2	PrebioticsIBA 05/2021 - 07/2020
2	Triglycerides (Triacylglycerol)IBA 05/2021 - 07/2020
2	rho-Associated KinasesIBA 01/2021 - 09/2011
2	Sucrose (Saccharose)IBA 11/2020 - 09/2011
2	MicroRNAs (MicroRNA)IBA 10/2020 - 05/2010
2	ZincIBA 07/2020 - 11/2011
2	AcidsIBA 07/2020 - 12/2012
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 07/2020 - 07/2019
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019 - 03/2011
2	Phenobarbital (Luminal)FDA Link 07/2019 - 10/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 07/2010
2	Cysteine (L-Cysteine)FDA Link 03/2018 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 06/2017 - 10/2016
2	AzoxymethaneIBA 03/2016 - 06/2013
2	OligosaccharidesIBA 03/2016 - 08/2013
2	Interleukin-17 (Interleukin 17)IBA 06/2014 - 02/2011
2	rebamipideIBA 12/2012 - 09/2011
2	Chemotactic FactorsIBA 09/2012 - 03/2011
2	polaprezinc (Z 103)IBA 11/2011 - 07/2010
2	HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA 09/2011 - 01/2011
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2011 - 07/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2011 - 01/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2010 - 01/2006
2	AdiponectinIBA 03/2008 - 03/2008
2	RNA (Ribonucleic Acid)IBA 01/2006 - 01/2004
1	Interleukin-12 Subunit p35IBA 01/2024
1	Amino Acids FDA Link 01/2024
1	Alanine (L-Alanine)FDA Link 01/2024
1	Interleukin-23 (Interleukin 23)IBA 01/2024
1	Interleukin-23 Subunit p19IBA 01/2024

Therapy/Procedure

7	Therapeutics 11/2022 - 07/2010
6	Enema (Enemas) 01/2021 - 07/2010
2	Intraperitoneal Injections 01/2024 - 01/2015
2	Kampo Medicine (Kampo) 01/2024 - 01/2011
2	Drug Therapy (Chemotherapy) 06/2022 - 03/2017
2	Rectal Administration 01/2021 - 11/2019